An iron-based T 1 contrast agent made of iron-phosphate complexes: In vitro and in vivo studies

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 20, Issue 1, 2007, Pages 27-37

  Rodríguez, Elisenda ^a   Simoes, Rui V ^b,c   Roig, Anna ^a   Molins, Elies ^a   Nedelko, Nataliya ^d   Ślawska Waniewska, Anna ^d   Aime, Silvio ^e   Arús, Carles ^c   Cabañas, Miquel E ^c   Sanfeliu, Coral ^f   Cerdán, Sebastián ^g   García Martín, Maria Luisa ^g  

^a INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA ICMAB CSIC   (Spain)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d INSTITUTE OF PHYSICS   (Poland)

^e UNIVERSITY OF TURIN   (Italy)

^f INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^g INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Fe8; Iron phosphate particles; Magnetic resonance imaging; T 1 contrast agent

Indexed keywords

AMINE; CONTRAST MEDIUM; FERRIC PHOSPHATE; IRON COMPLEX; PHOSPHATE; IRON DERIVATIVE; POTASSIUM DERIVATIVE; POTASSIUM DIHYDROGEN PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN TUMOR; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; FEMALE; GLIOMA; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOSSBAUER SPECTROSCOPY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; TUMOR DIAGNOSIS; ANIMAL; RAT; TUMOR CELL LINE;

MUS; PHOS;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; IRON COMPOUNDS; MAGNETIC RESONANCE IMAGING; MICE; PHOSPHATES; POTASSIUM COMPOUNDS; RATS;

EID: 33846947558     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-006-0066-7     Document Type: Article

References (29)

1. Lauffer RB (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 87:901-927
2. Merbach A, Tóth E, Helm T (2001) Relaxivity of gadolinium (III) complexes: theory and mechanism. In:Merbach A, Tóth E (eds.) The chemistry of contrast agent in medical resonance imaging. Willey-VCH, Chichester, pp 46-119
3. Caravan PJ, Ellison J, McMurry J, Lauffer RB (1999) Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 99:2293-2352
4. Aime S, Frullano L, Crich SG (2002) Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew Chem Int Edn 41:1017-1019
5. Laurent S, Vander Elst L, Yanjun F, Muller RN (2004) Synthesis and physicochemical characterization of Gd-DTPA-B(sLex)A, a New MRI contrast agent targeted to inflammation. Bioconjugate Chem 15:99-103
6. 3+ chelates. J Biol Inorg Chem 10:78-86
7. Boudreau RJ, Frick MP, Levey RM, Lund G, Sirr SA, Loken MK (1986) The preliminary evaluation of Mn DTPA as a potential contrast agent for nuclear magnetic resonance imaging. Am J Physiol Imaging 1(1):19-25
8. Kupka T, Dziegielewski JO, Pasterna G, Malecki JG (1992) Copper-D-penicillamine complex as potential contrast agent for MRI. Magn Reson Imaging 10(5):855-858
9. Davies JA, Dutremez SG, Hockensmith CM, Keck R, Richardson N, Selman S, Smith DA, Ulmer CW, Wheatley LS, Zeiss J (1996) Iron-based second-sphere contrast agents for magnetic resonance imaging: development of a model system and evaluation of iron (III) tris (tironate) complex in rats. Acad Radiol 3(11):936-945
10. Colet J-M, Piérart C, Seghi F, Gabric I, Muller RN (1998) Intravascular and intracellular hepatic relaxivities of super-paramagnetic particles: an isolated and perfused organ pharmacokinetics study. J Magn Reson 134:199-205
11. Artemov D., Mori N., Okollie B., Bhujwalla Z (2003) MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 49:403-408
12. Richardson N, Davies JA, Radüchel B (1999) Iron (III)-based contrast agent for magnetic resonance imaging. Polyhedron 18:2457-2482
13. Rodríguez E, Roig A, Molins E, Arús C, Quintero MR, Cabañas ME, Cerdán S, Lopez-Larrubia P, Sanfeliu C (2005) In vitro characterization of an Fe8 cluster as potential MRI contrast agent. NMR Biomed 18(5):300-307
14. Sirlin CB, Vera DR, Caballero MB, Buxton RB, Mattrey RF (2004) Gadolinium-DTPA-dextran a macromolecular MR blood pool contrast agent. Acad Radiol 11(12):1361-1369
15. Corot C, Robert P, Lancelot E, Martinell A, Santus R (2005) Distribution of gadomelitol in a human breast tumour model in mice. Magn Reson Mater Phy 18(3):138-143
16. 2O. Angew Chem Int Ed Engl 1:77-78
17. Seligman AM, Shear MJ (1939) Studies in carcinogenesis. VIII. Experimental production of Brain tumors in mice with methylcholanthrene. Am J Cancer 37:364-395
18. Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, Zagzag D, Turnbull DH (2003) Dynamic, contrast-enhanced perfusion MRI inmouse gliomas: correlation with histopathology. Magn Reson Med 49(5):848-855
19. Rémy C, Arús C, Ziegler A, Lai ES, Moreno A, Le Fur Y, Décorps M (1994) In vivo, ex vivo, and in vitro one- and two dimensional nuclear magnetic resonance spectroscopy of an intracerebral glioma in rat brain: assignment of resonances. J Neurochem 62(1):166-179
20. Keilhoff G, Wolf G(1993) Comparison of double fluorescence staining and LDH-test for monitoring cell viability in vitro. Neuroreport 5:129-132
21. Suber L, Foglia S, Romero H, Montone A, Roig A, Casas Ll, Molins E, Fiorani D (2004) Synthesis, morphological-structural characterization and magnetic properties of amorphous iron(III)-oxyhydroxy-phosphate nanoparticles. J Solid State Chem Soc 177:2439-2447
22. 2O (Fe8) cluster in aqueous solution by spectroscopic and magnetic methods. Polyhedron 25:113-118
23. Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, Zagzag D, Turnbull DH (2003) Dynamic, contrast-enhanced perfusion MRI inmouse gliomas: correlation with histopathology. Magn Reson Med 49(5):848-855
24. Meyer MH, Dulde E, Meyer RA (2004) The genomic response of the mouse kidney to low-phosphate diet is altered in X-linked hypophosphatemia. Physiol Genomics 18:4-11
25. Zoula S, Herigault G, Ziegler A, Farion R, Décorps M, Rémy C (2003) Correlation between the occurrence of 1H-MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development. NMR Biomed 16(4):199-212
26. Locatelli F, Rossi F (2005) Incidence and pathogenesis of tumor lysis syndrome. Contrib Nephrol 147:61-68
27. Mansour AN, Thompson C, Theil EC, Chasteen ND, Sayers DE (1985) Fe(III)·ATP complexes. Models for ferritin and other polynuclear iron complexes with phosphates. JBC 13:7975-7979
28. Zhang Z, van den Bos EJ, Wielopolski PA, de Jong-Popijus M, Duncker DJ, Krestin GP (2004) High-resolution magnetic resonance imaging of iron-labeled myoblasts using a standard 1.5-T clinical scanner. Magn Reson Mater Phy 17:201-209
29. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW (2005) Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 54:769-774